Table 1.

Detailed information of 16 phenolamides detected in this study.

No.	Peak no.	Level	Ret. Time (min)*	Putative phenolamides name	AMPE1	AMPE2	BBE1	BBE2	ZYE1	ZYE2
1	n0130	C	4.8	N-Feruloylputrescine	√	√	√	√	√	√
2	n0183	B	6.45	N-(coumaroyl-O-hexoside)-spermidine	√	√	√	√	√	√
3	n0271	C	9.63	Dicoumaroylputrescine	√	√	√	√	√	√
4	n0380	B	5.64	N-(caffeoyl-O-hexoside)-spermidine	√	√	√	√	√	√
5	n0381-1	B	9.9	Diferuloylputrescine	√	√	√	√	√	√
6	n0412	C	6.24	N-(feruloyl-O-hexoside)-spermidine	√	√	√	√	√	√
7	n0436	C	6.73	N1, N10-Diferuloylspermidine	√	√	√	√	√	√
8	n0439	B	10.2	N’,N’’-Feruloyl,caffeoyl-spermidine derivative	√	√	√	√	√	√
9	n0945	C	6.59	N-Coumaroylputrescine	√	√	√	√	√	√
10	n0979	B	5.08	N-Coumaroylagmatine	√	√	√	√	√	√
11	n1048	B	4.63	N-Coumaroyl-spermidine derivative	√	√	×	√	×	√
12	n1243	C	10.8	N,N-Di-coumaroyl-N-feruloylspermidine	√	√	√	√	√	√
13	n1376	B	5.33	Feruloylagmatine derivative	√	√	√	√	√	√
14	n1377	C	7.69	N-Feruloylagmatine	√	√	√	√	√	√
15	n1394	C	5.52	N-Feruloyl, N-methoxyagmatine	√	√	√	√	√	√
16	n1544-1	B	11.3	N,N-caffeoyl, Feruloyl-spermidine derivative	√	√	√	√	√	√

*Ret. Time, Retention time, in minutes (difference in Ret.Time between ES(+) and ES(-) modes was less than XX minutes), Identification level (B; C)- (B) MS/MS; (C) MSE.